留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

泛发性脓疱型银屑病患者外周血单个核细胞甲基化酶及甲基化CpG结合蛋白mRNA的表达水平

朱腾 晋红中

朱腾, 晋红中. 泛发性脓疱型银屑病患者外周血单个核细胞甲基化酶及甲基化CpG结合蛋白mRNA的表达水平[J]. 协和医学杂志, 2019, 10(4): 358-363. doi: 10.3969/j.issn.1674-9081.2019.04.009
引用本文: 朱腾, 晋红中. 泛发性脓疱型银屑病患者外周血单个核细胞甲基化酶及甲基化CpG结合蛋白mRNA的表达水平[J]. 协和医学杂志, 2019, 10(4): 358-363. doi: 10.3969/j.issn.1674-9081.2019.04.009
Teng ZHU, Hong-zhong JIN. mRNA Expression of Methylase and Methyl-CpG Binding Protein in Peripheral Blood Mononuclear Cells from Patients with Generalized Pustular Psoriasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 358-363. doi: 10.3969/j.issn.1674-9081.2019.04.009
Citation: Teng ZHU, Hong-zhong JIN. mRNA Expression of Methylase and Methyl-CpG Binding Protein in Peripheral Blood Mononuclear Cells from Patients with Generalized Pustular Psoriasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 358-363. doi: 10.3969/j.issn.1674-9081.2019.04.009

泛发性脓疱型银屑病患者外周血单个核细胞甲基化酶及甲基化CpG结合蛋白mRNA的表达水平

doi: 10.3969/j.issn.1674-9081.2019.04.009
基金项目: 

国家自然科学基金面上项目 81773331

中国医学科学院医学与健康科技创新工程 2017-I2M-B & R-01

中央保健科研课题 W2017BJ21

详细信息
    通讯作者:

    晋红中电话:010-69151542, E-mail: jinhongzhong@263.net

  • 中图分类号: R758.63

mRNA Expression of Methylase and Methyl-CpG Binding Protein in Peripheral Blood Mononuclear Cells from Patients with Generalized Pustular Psoriasis

More Information
  • 摘要:   目的  观察泛发性脓疱型银屑病(generalized pustular psoriasis,GPP)患者外周血单个核细胞(peripheral blood mononuclear cell,PBMC)中DNA甲基转移酶及甲基化CpG结合蛋白(methyl-CpG binding protein,MeCP)mRNA的表达情况,初步探讨DNA甲基化在GPP中可能的作用机制。  方法  回顾性收集2015年12月至2016年12月在北京协和医院皮肤科门诊或住院治疗的9例GPP患者临床资料;随机选取10例同期在医院接受健康体检的健康人做为对照,年龄和性别与GPP患者相匹配。分别留取10 ml肘正中静脉血,采用密度梯度离心法分离PBMC,应用Trizol法提取PBMC总RNA,采用实时PCR法检测DNMT1、DNMT3a、DNMT3b、MBD1、MBD2、MBD3、MBD4及MeCP2的mRNA表达水平,并分析年龄及病情严重程度与mRNA表达水平的相关性。  结果  GPP患者PBMC中DNMT3a、DNMT3b、MBD1、MBD2、MBD4的mRNA表达水平较健康对照组升高[DNMT3a:0.000 17(0.000 06, 0.001 15)比0.000 03(0.000 02,0.000 04);DNMT3b:0.000 04±0.000 02比0.000 02±0.000 01;MBD1:为0.001 01±0.000 45比0.000 46±0.000 15;MBD2:0.002 61±0.000 39比0.001 85±0.000 52;MBD4:0.004 29±0.001 60比0.001 57±0.000 55, P均<0.05], 年龄及疾病严重度与上述因子mRNA的相对表达水平无相关性(P均>0.05)。  结论  GPP患者体内甲基化相关调控基因表达异常,但与年龄和疾病严重程度不相关。
    利益冲突  无
  • 图  1  泛发性脓疱型银屑病患者外周血单个核细胞荧光定量PCR流程图

    图  2  泛发性脓疱型银屑病患者外周血单个核细胞中RNA琼脂糖凝胶电泳图

    表  1  GPP患者甲基化相关调控基因引物序列

    基因名称 上游引物(5′→3′) 下游引物(5′→3′)
    DNMT1 5′-GAGCTACCACGCAGACATCA-3′ CGAGGAAGTAGAAGCGGTTG
    DNMT3a 5′-CCGGAACATTGAGGACATCT-3′ CAGCAGATGGTGCAGTAGGA
    DNMT3b 5′-CCCATTCGAGTCCTGTCATT-3′ GGTTCCAACAGCAATGGACT
    MBD1 5′-CACCCTCTTCGACTTCAAACAAG-3′ CAACCTGACGTTTCCGAGTCTT
    MBD2 5′-AACCCTGCTGTTTGGCTTAAC-3′ CGTACTTGCTGTACTCGCTCTTC
    MBD3 5′-CCGCTCTCCTTCAGTAAATGTAAC-3′ GGCTGGAGTTTGGTTTTCAGAA
    MBD4 5′-TGGTGGTGCATGCCTGTAAT-3′ TGAGACAGGGTCTCTCTCTGTCAT
    MeCP2 5′-CCCCACCCTGCCTGAA-3′ GATGTGTCGCCTACCTTTTCG
    GPP:泛发性脓疱型银屑病;DNMT:DNA甲基转移酶;MBD:甲基化CpG结合域; MeCP:甲基化CpG结合蛋白
    下载: 导出CSV

    表  2  GPP患者及健康人外周血单个核细胞中DNMT和MeCP mRNA相对表达量的比较

    基因 GPP组(n=9) 健康对照组(n=10) t/Z P
    DNMT1 0.001 77±0.000 76 0.001 83±0.002 00 -0.097 0.924
    DNMT3a 0.000 17
    (0.000 06, 0.001 15)
    0.000 03
    (0.000 02, 0.000 04)
    -2.598 0.009
    DNMT3b 0.000 04±0.000 02 0.000 02±0.000 01 2.326 0.021
    MeCP2 0.002 08±0.000 84 0.001 79±0.000 83 0.716 0.487
    MBD1 0.001 01±0.000 45 0.000 46±0.000 15 3.060 0.000
    MBD2 0.002 61±0.000 39 0.001 85±0.000 52 3.284 0.005
    MBD3 0.000 02±0.000 01 0.000 03±0.000 01 -1.828 0.088
    MBD4 0.004 29±0.001 60 0.001 57±0.000 55 4.447 0.003
    GPP、DNMT、MBD、MeCP:同表 1
    下载: 导出CSV

    表  3  GPP患者年龄和疾病严重程度与DNMT及MeCP mRNA表达水平的相关分析

    风险因素 基因 r P
    年龄 DNMT1 -0.319 0.402
    DNMT3a -0.067 0.864
    DNMT3b -0.487 0.183
    MBD1 -0.235 0.542
    MBD2 -0.252 0.513
    MBD3 -0.328 0.389
    MBD4 -0.202 0.603
    MeCP2 0.050 0.897
    病情严重程度 DNMT1 -0.134 0.732
    DNMT3a 0.098 0.802
    DNMT3b -0.241 0.533
    MBD1 -0.241 0.533
    MBD2 -0.009 0.982
    MBD3 -0.178 0.646
    MBD4 -0.134 0.732
    MeCP2 -0.285 0.457
    GPP、DNMT、MBD、MeCP:同表 1
    下载: 导出CSV
  • [1] Reich A. Interleukin-17 blockade in generalized pustular psoriasis-new hope for severely ill patients [J]. Br J Dermatol, 2017, 176: 572-573. doi:  10.1111/bjd.14987
    [2] Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis [J]. N Engl J Med, 2011, 365: 620-628. doi:  10.1056/NEJMoa1013068
    [3] Jordan CT, Cao L, Roberson ED, et al. PSORS2 is due to mutations in CARD14 [J]. Am J Hum Genet, 2012, 90: 784-795. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=e523f113631af97f465990c9cd244b11
    [4] Sugiura K, Takemoto A, Yamaguchi M, et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist [J]. J Invest Dermatol, 2013, 133: 2514-2521. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=77c0318cba979d3142142b831c593252
    [5] Korber A, Mssner R, Renner R, et al. Mutations in IL36RN in patients with generalized pustular psoriasis [J]. J Invest Dermatol, 2013, 133: 2634-2637. doi:  10.1038/jid.2013.214
    [6] Sharma U, Rando OJ. Metabolic inputs into the epigenome [J]. Cell Metab, 2017, 25: 544-558. doi:  10.1016/j.cmet.2017.02.003
    [7] Chen SH, Lv QL, Hu L. DNA methylation alterations in the pathogenesis of lupus [J]. Clin Exp Immunol, 2017, 187: 185-192. doi:  10.1111/cei.12877
    [8] 桂欣钰, 晋红中.异常DNA甲基化与免疫性皮肤病[J].协和医学杂志, 2017, 8: 46-49. doi:  10.3969/j.issn.1674-9081.2017.03.009
    [9] Elhamamsy AR. Role of DNA methylation in imprinting disorders: an updated review [J]. J Assist Reprod Genet, 2017, 34:549-562. doi:  10.1007/s10815-017-0895-5
    [10] Gowher H, Liebert K, Hermann A, et al. Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA- (cytosine-C5)-methyltransferases by DNMT3L [J]. J Biol Chem, 2005, 280: 13341-13348. doi:  10.1074/jbc.M413412200
    [11] Lopez-Serra L, Esteller M. Proteins that bind methylated DNA and human cancer: reading the wrong words [J]. Br J Cancer, 2008, 98: 1881-1885. doi:  10.1038/sj.bjc.6604374
    [12] Umezawa Y, Ozawa A, Kawasima T, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity [J]. Arch Dermatol Res, 2003, 295 Suppl 1: S43-S54. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=6cfa5fec4d91fd205e6df0a095ddfacc
    [13] Onoufriadis A, Simpson MA, Pink AE, et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis [J]. Am J Hum Genet, 2011, 89: 432-437. doi:  10.1016/j.ajhg.2011.07.022
    [14] Sugiura K, Muto M, Akiyama M. CARD14c.526G4C(p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort [J]. J Invest Dermatol, 2014, 134: 1755-1757. doi:  10.1038/jid.2014.46
    [15] Bestor TH. The DNA methyltransferases of mammals [J]. Hum Mol Genet, 2000, 9: 2395-2402. doi:  10.1093/hmg/9.16.2395
    [16] Tajima S, Suetake I, Takeshita K, et al. Domain structure of the DNMT1, DNMT3a, and DNMT3b DNA methyltrans-ferases [J]. Adv Exp Med Biol, 2016, 945: 63-86. http://europepmc.org/abstract/med/27826835
    [17] Wood KH, Johnson BS, Welsh SA, et al. Tagging methyl-CpG-binding domain proteins reveals different spatiotemporal expression and supports distinct functions [J]. Epigenomics, 2016, 8: 455-473. doi:  10.2217/epi-2015-0004
    [18] Pandey S, Pruitt K. Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon and prostate [J]. Biochem Cell Biol, 2017, 95: 368-378. doi:  10.1139/bcb-2016-0154
  • 加载中
图(2) / 表(3)
计量
  • 文章访问数:  282
  • HTML全文浏览量:  24
  • PDF下载量:  99
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-04-19
  • 刊出日期:  2019-07-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!